Prostate Cancer & PSA Tumors News Articles

Prostate Cancer News

PROSTATE CANCER ADVISOR

Prostate Cancer News

Bone Metastases

New Guideline Issued for Managing Advanced Prostate Cancer

Three major medical organizations have issued recommendations for the diagnosis and treatment of advanced prostate cancer, including metastatic hormone-sensitive disease and nonmetastatic and metastatic castration-resistant disease.
Small army of white pills

Metformin Found Not to Prevent Prostate Cancer

A study looking at the effect of genetic variations on the pharmacologic activity of metformin found that use of the drug was associated with an increased risk of prostate cancer overall and of high-grade prostate cancer.
PCa bone metastases.

PARP Inhibitor Approved for BRCA-Mutated mCRPC

FDA has approved rucaparib for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer in men previously treated with androgen-receptor directed therapy and taxane-based chemotherapy.

Carboplatin Possibly Beneficial in Refractory mCRPC

In a retrospective study, addition of carboplatin to chemotherapy regimens improved survival in men with metastatic castration-resistant prostate cancer whose disease progressed on second-generation hormone therapy.